ArticleCureus2025
Endovascular Treatment of Renal Artery Pseudoaneurysm Following Laparoscopic Partial Nephrectomy: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This report presents the case of a patient diagnosed with stage I renal cell carcinoma (RCC), who was treated with a laparoscopic partial nephrectomy and, subsequently, percutaneous transarterial embolization (PTAE) due to a renal pseudoaneurysm secondary to partial nephrectomy. A laparoscopic partial nephrectomy was performed, sparing the healthy renal tissue. Four days after surgery, the patient's hematocrit count decreased by 8 points, and macroscopic hematuria was noted. PTAE of a renal pseudoaneurysm was indicated due to refractory bleeding. Adequate bleeding control and preservation of the renal parenchyma were achieved. Progress in early diagnosis of malignancy has resulted in the detection of more than 60% of RCCs at stage T1. In this scenario, new surgical techniques, which spare the renal parenchyma, have become the recommended therapeutic option in patients with early renal tumors. Likewise, dealing with complications arising from these new surgical techniques should also focus on maintaining kidney tissue integrity. We highlight the growing trend to implement minimally invasive therapies in patient care while pointing out the scarcity of studies contrasting immediate imaging results and clinically significant outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.